The 2CARE study of coenzyme Q for Huntington’s disease was halted early because an analysis of the results to date showed that it was very unlikely to show positive results. The study, called 2CARE, was designed to test whether a treatment called coenzyme Q10 could slow the progression of HD.
Largest ever therapeutic trial for Huntington’s disease ends in disappointment
Home » Posts tagged "Theraputics"
©2023 JPND Research | Privacy Policy | Cookie Policy | Hosted By SmartHost | Site by Ten10